Compounds > tacrolimus

tacrolimus and Wiskott-Aldrich-Syndrome

tacrolimus has been researched along with Wiskott-Aldrich-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for tacrolimus and Wiskott-Aldrich-Syndrome

ArticleYear
A case of red lunulae after haematopoietic stem cell transplantation.
    European journal of dermatology : EJD, 2018, Jun-01, Volume: 28, Issue:3

    Topics: Alopecia; Erythema; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Nail Diseases; Tacrolimus; Wiskott-Aldrich Syndrome

2018
Topical tacrolimus is effective against eczema in Wiskott-Aldrich syndrome (WAS).
    Acta paediatrica (Oslo, Norway : 1992), 2007, Volume: 96, Issue:2

    The Wiskott-Aldrich syndrome is a rare X-linked immunodeficiency characterized by microplatelet thrombocytopenia and eczema. Eczema may be severe and facilitate entry of microorganism into the host.. We report for the first time that eczema in infants with WAS can be effectively treated with topical ttacrolimus.

    Topics: Administration, Cutaneous; Eczema; Humans; Immunosuppressive Agents; Infant; Male; Tacrolimus; Treatment Outcome; Wiskott-Aldrich Syndrome

2007